A quick tour of GLP-1 and what the drugs do GLP-1 (glucagon-like peptide-1) is a gut hormone released by L-cells in the small intestine when you eat, especially carbohydrates and fats
GLP-1 in the brain stem is activated due to stress and causes a loss of appetite
Additionally, as the body undergoes hormonal fluctuations during weight loss, menstrual cycles may become less predictable for a time
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has shown even greater efficacy in some studies, with weight reductions of approximately 20% in the SURMOUNT-1 trial
Each pill contains 3mg Retatrutide and is designed for simple once-daily use within the intended research framework
While youre here, take our regulatory intelligence chatbot for a spinfree: #Pharma #OTC #RegulatoryIntelligence #FreyrGRI #ComplianceSimplified To view or add a comment, sign in The FDA announces its upcoming research priorities for generic drugs in 2026